CD
ABBV icon

Chapin Davis’s AbbVie ABBV Stock Holding History

Chapin Davis’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.07M Sell
15,545
-218
-1% -$55.9K 0.78% 29
2026
Q2 		$3.97M Buy
15,763
+1,500
+11% +$323K 0.7% 31
2026
Q1 		$3.1M Buy
14,263
+847
+6% +$188K 0.69% 32
2025
Q4 		$3.07M Sell
13,416
-52
-0.4% -$11.8K 0.72% 35
2025
Q3 		$3.12M Buy
13,468
+462
+4% +$94.1K 0.77% 30
2025
Q2 		$2.41M Buy
13,006
+1,487
+13% +$276K 0.67% 35
2025
Q1 		$2.41M Buy
11,519
+1,892
+20% +$368K 0.82% 25
2024
Q4 		$1.9M Hold
9,627
– – 0.62% 37
2024
Q3 		$1.9M Buy
9,627
+215
+2% +$40.1K 0.62% 38
2024
Q2 		$1.61M Buy
9,412
+340
+4% +$56.3K 0.55% 42
2024
Q1 		$1.65M Sell
9,072
-2,400
-21% -$414K 0.6% 35
2023
Q4 		$1.78M Buy
11,472
+1,125
+11% +$164K 0.75% 31
2023
Q3 		$1.54M Sell
10,347
-739
-7% -$108K 0.74% 33
2023
Q2 		$1.49M Buy
11,086
+43
+0.4% +$6.31K 0.71% 32
2023
Q1 		$1.76M Buy
11,043
+179
+2% +$27.4K 0.91% 25
2022
Q4 		$1.76M Buy
+10,864
New +$1.67M 1.02% 26

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Chapin Davis's ABBV Position: Q3 2026 in Review

Chapin Davis reduced its AbbVie (ABBV) stake by 1.4% in Q3 2026, selling an estimated $55.9K and leaving 15,545 shares worth $4.07M. The position accounts for 0.78% of the portfolio, ranked #29.

Chapin Davis first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Chapin Davis held 15,545 shares of AbbVie worth $4.07M as of Q3 2026.
  • Chapin Davis sold 218 AbbVie shares in Q3 2026, an estimated $55.9K.
  • AbbVie made up 0.78% of Chapin Davis's portfolio in Q3 2026, its #29 holding.
  • Chapin Davis first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Chapin Davis's 13F filing for Q3 2026, filed 9 Oct 2026.